AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

3.86
Delayed Data
As of Mar 31
 +0.19 / +5.18%
Today’s Change
3.58
Today|||52-Week Range
12.35
-42.64%
Year-to-Date

Today’s Trading

Previous close3.67
Today’s open3.68
Day’s range-- - --
Volume711,019
Average volume (3 months)644,075
Market cap$160.4M
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)-54.24%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)+46.60%
Revenue growth (last year)-82.32%
P/E ratioNM
Price/Sales56.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GLYCGlycoMimetics Inc-0.04-0.48%
CNDOCoronado Biosciences...+0.31+8.76%
INNLInnocoll AG0.000.00%
SNSSSunesis Pharmaceutic...0.000.00%
Data as of 03/31/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$5.2M
Annual profit (last year)-$33.4M
Net profit margin-639.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Lead Director
Howard B. Rosen
Chief Financial Officer
Timothy E. Morris
Corporate headquarters
Redwood City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account